⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26118481 | 1.00 | — | — | |
| SCHEMBL31278379 | 1.00 | — | — | |
| SCHEMBL26114998 | 0.90 | THRB (0.31) | — | |
| SCHEMBL30587224 | 0.90 | THRB (0.31) | — | |
| SCHEMBL33526107 | 0.89 | EIF4EBP1 (0.31) | — | |
| SCHEMBL31278508 | 0.89 | THRB (0.31) | — | |
| SCHEMBL30587198 | 0.89 | THRB (0.31) | — | |
| SCHEMBL26115041 | 0.89 | THRB (0.31) | — | |
| SCHEMBL26114057 | 0.86 | — | — | |
| SCHEMBL30587288 | 0.86 | KDM4E (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4499233-A1 | KRAS INHIBITORS | Eli Lilly and Company (US) | 2025-02-05 | — | — | EP | disclosed |
| WO-2023183585-A1 | KRAS INHIBITORS | ELI LILLY AND COMPANY (US) | 2023-09-28 | — | — | WO | disclosed |